Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: UCART19
ID: S900007600


  • Wikipedia: An experimental immunotherapy against leukemia using genetically modified T-cells developed by Cellectis. Unlike personalized medicine, UCART19 is hoped to be ?off-the-shelf?.[1] Developed for Chronic lymphocytic leukemia (CLL) and Acute lymphoblastic leukemia (ALL)
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

  • UCART19

Registry Number

  • S900007600